Novel biomarker SYT12 may contribute to predicting papillary thyroid cancer outcomes.

ABSTRACT:

Aim

To investigate biomarkers for predicting papillary thyroid cancer outcomes.

Materials & methods

The expression of biomarkers (ITGA2, SYT12 and CDH3) was studied in a prospective cohort of patients with papillary thyroid cancer. Three outcomes of initial metastases, baseline status and longitudinal status were analyzed and correlated with the biomarkers.

Results

SYT12 provided the best prediction of initial metastasis (sensitivity: 72%; specificity: 54%). SYT12 had the highest accuracy for predicting longitudinal status (sensitivity: 100%; specificity: 47%). The best performance for longitudinal status resulted from combining SYT12 with American Thyroid Association risk stratification, with sensitivity and specificity of 88 and 73

SUBMITTER: Jonklaas J 

PROVIDER: S-EPMC5729603 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature